産後うつ病治療薬の世界市場（～2026年）

• 英文タイトル：Global Postpartum Depression Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04333
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は産後うつ病治療薬のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミン酸化酵素阻害薬）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別産後うつ病治療薬の競争状況、市場シェア
・世界の産後うつ病治療薬市場：種類別市場規模 2015年-2020年（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミン酸化酵素阻害薬）
・世界の産後うつ病治療薬市場：種類別市場規模予測 2021年-2026年（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミン酸化酵素阻害薬）
・世界の産後うつ病治療薬市場：用途別市場規模 2015年-2020年（病院薬局、オンライン薬局、小売薬局）
・世界の産後うつ病治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、オンライン薬局、小売薬局）
・北米の産後うつ病治療薬市場分析：米国、カナダ
・ヨーロッパの産後うつ病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの産後うつ病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の産後うつ病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの産後うつ病治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Allegan、Eli Lilly、H. Lundbeck、GlaxoSmithKline、Solvay、AstraZeneca、Novartis、Sage Therapeutics
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Postpartum depression is a prevalent disorder affecting many women of reproductive age.
Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depression.

Market Analysis and Insights: Global Postpartum Depression Therapeutics Market
The global Postpartum Depression Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Postpartum Depression Therapeutics Scope and Market Size
Postpartum Depression Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Postpartum Depression Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Allegan
Eli Lilly
H. Lundbeck
GlaxoSmithKline
Solvay
AstraZeneca
Novartis
Sage Therapeutics

Market segment by Type, the product can be split into
Selective Serotonin Reuptake Inhibitors
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Postpartum Depression Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Postpartum Depression Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Selective Serotonin Reuptake Inhibitors
1.4.3 Serotonin Norepinephrine Reuptake Inhibitors
1.4.4 Tricyclic Antidepressants
1.4.5 Monoamine Oxidase Inhibitors
1.5 Market by Application
1.5.1 Global Postpartum Depression Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Postpartum Depression Therapeutics Market Perspective (2015-2026)
2.2 Global Postpartum Depression Therapeutics Growth Trends by Regions
2.2.1 Postpartum Depression Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Postpartum Depression Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Postpartum Depression Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Postpartum Depression Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Postpartum Depression Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Postpartum Depression Therapeutics Players by Market Size
3.1.1 Global Top Postpartum Depression Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Postpartum Depression Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Postpartum Depression Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Postpartum Depression Therapeutics Market Concentration Ratio
3.2.1 Global Postpartum Depression Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Postpartum Depression Therapeutics Revenue in 2019
3.3 Postpartum Depression Therapeutics Key Players Head office and Area Served
3.4 Key Players Postpartum Depression Therapeutics Product Solution and Service
3.5 Date of Enter into Postpartum Depression Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Postpartum Depression Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Postpartum Depression Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Postpartum Depression Therapeutics Market Size by Application (2015-2020)
5.2 Global Postpartum Depression Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Postpartum Depression Therapeutics Market Size (2015-2020)
6.2 Postpartum Depression Therapeutics Key Players in North America (2019-2020)
6.3 North America Postpartum Depression Therapeutics Market Size by Type (2015-2020)
6.4 North America Postpartum Depression Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Postpartum Depression Therapeutics Market Size (2015-2020)
7.2 Postpartum Depression Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Postpartum Depression Therapeutics Market Size by Type (2015-2020)
7.4 Europe Postpartum Depression Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Postpartum Depression Therapeutics Market Size (2015-2020)
8.2 Postpartum Depression Therapeutics Key Players in China (2019-2020)
8.3 China Postpartum Depression Therapeutics Market Size by Type (2015-2020)
8.4 China Postpartum Depression Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Postpartum Depression Therapeutics Market Size (2015-2020)
9.2 Postpartum Depression Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Postpartum Depression Therapeutics Market Size by Type (2015-2020)
9.4 Japan Postpartum Depression Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Postpartum Depression Therapeutics Market Size (2015-2020)
10.2 Postpartum Depression Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Postpartum Depression Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Postpartum Depression Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Postpartum Depression Therapeutics Market Size (2015-2020)
11.2 Postpartum Depression Therapeutics Key Players in India (2019-2020)
11.3 India Postpartum Depression Therapeutics Market Size by Type (2015-2020)
11.4 India Postpartum Depression Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Postpartum Depression Therapeutics Market Size (2015-2020)
12.2 Postpartum Depression Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Postpartum Depression Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Postpartum Depression Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Postpartum Depression Therapeutics Introduction
13.1.4 Pfizer Revenue in Postpartum Depression Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Allegan
13.2.1 Allegan Company Details
13.2.2 Allegan Business Overview
13.2.3 Allegan Postpartum Depression Therapeutics Introduction
13.2.4 Allegan Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.2.5 Allegan Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Postpartum Depression Therapeutics Introduction
13.3.4 Eli Lilly Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 H. Lundbeck
13.4.1 H. Lundbeck Company Details
13.4.2 H. Lundbeck Business Overview
13.4.3 H. Lundbeck Postpartum Depression Therapeutics Introduction
13.4.4 H. Lundbeck Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.4.5 H. Lundbeck Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Postpartum Depression Therapeutics Introduction
13.5.4 GlaxoSmithKline Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Solvay
13.6.1 Solvay Company Details
13.6.2 Solvay Business Overview
13.6.3 Solvay Postpartum Depression Therapeutics Introduction
13.6.4 Solvay Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.6.5 Solvay Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Postpartum Depression Therapeutics Introduction
13.7.4 AstraZeneca Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Postpartum Depression Therapeutics Introduction
13.8.4 Novartis Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Sage Therapeutics
13.9.1 Sage Therapeutics Company Details
13.9.2 Sage Therapeutics Business Overview
13.9.3 Sage Therapeutics Postpartum Depression Therapeutics Introduction
13.9.4 Sage Therapeutics Revenue in Postpartum Depression Therapeutics Business (2015-2020)
13.9.5 Sage Therapeutics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Postpartum Depression Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Postpartum Depression Therapeutics Revenue
Table 3. Ranking of Global Top Postpartum Depression Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Postpartum Depression Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Selective Serotonin Reuptake Inhibitors
Table 6. Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Table 7. Key Players of Tricyclic Antidepressants
Table 8. Key Players of Monoamine Oxidase Inhibitors
Table 9. Global Postpartum Depression Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Postpartum Depression Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Postpartum Depression Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Postpartum Depression Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Postpartum Depression Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Postpartum Depression Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Postpartum Depression Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Postpartum Depression Therapeutics Players
Table 20. Global Postpartum Depression Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Postpartum Depression Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Postpartum Depression Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postpartum Depression Therapeutics as of 2019)
Table 23. Global Postpartum Depression Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Postpartum Depression Therapeutics Product Solution and Service
Table 26. Date of Enter into Postpartum Depression Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Postpartum Depression Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Postpartum Depression Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Postpartum Depression Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Postpartum Depression Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Postpartum Depression Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Postpartum Depression Therapeutics Market Share (2019-2020)
Table 36. North America Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Postpartum Depression Therapeutics Market Share by Type (2015-2020)
Table 38. North America Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Postpartum Depression Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Postpartum Depression Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Postpartum Depression Therapeutics Market Share (2019-2020)
Table 42. Europe Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Postpartum Depression Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Postpartum Depression Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Postpartum Depression Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Postpartum Depression Therapeutics Market Share (2019-2020)
Table 48. China Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Postpartum Depression Therapeutics Market Share by Type (2015-2020)
Table 50. China Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Postpartum Depression Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Postpartum Depression Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Postpartum Depression Therapeutics Market Share (2019-2020)
Table 54. Japan Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Postpartum Depression Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Postpartum Depression Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Postpartum Depression Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Postpartum Depression Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Postpartum Depression Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Postpartum Depression Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Postpartum Depression Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Postpartum Depression Therapeutics Market Share (2019-2020)
Table 66. India Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Postpartum Depression Therapeutics Market Share by Type (2015-2020)
Table 68. India Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Postpartum Depression Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Postpartum Depression Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Postpartum Depression Therapeutics Market Share (2019-2020)
Table 72. Central & South America Postpartum Depression Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Postpartum Depression Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Postpartum Depression Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Postpartum Depression Therapeutics Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. Allegan Company Details
Table 82. Allegan Business Overview
Table 83. Allegan Product
Table 84. Allegan Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 85. Allegan Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Product
Table 89. Eli Lilly Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 90. Eli Lilly Recent Development
Table 91. H. Lundbeck Company Details
Table 92. H. Lundbeck Business Overview
Table 93. H. Lundbeck Product
Table 94. H. Lundbeck Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 95. H. Lundbeck Recent Development
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 100. GlaxoSmithKline Recent Development
Table 101. Solvay Company Details
Table 102. Solvay Business Overview
Table 103. Solvay Product
Table 104. Solvay Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 105. Solvay Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Product
Table 109. AstraZeneca Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 110. AstraZeneca Recent Development
Table 111. Novartis Business Overview
Table 112. Novartis Product
Table 113. Novartis Company Details
Table 114. Novartis Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 115. Novartis Recent Development
Table 116. Sage Therapeutics Company Details
Table 117. Sage Therapeutics Business Overview
Table 118. Sage Therapeutics Product
Table 119. Sage Therapeutics Revenue in Postpartum Depression Therapeutics Business (2015-2020) (Million US$)
Table 120. Sage Therapeutics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postpartum Depression Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Selective Serotonin Reuptake Inhibitors Features
Figure 3. Serotonin Norepinephrine Reuptake Inhibitors Features
Figure 4. Tricyclic Antidepressants Features
Figure 5. Monoamine Oxidase Inhibitors Features
Figure 6. Global Postpartum Depression Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Postpartum Depression Therapeutics Report Years Considered
Figure 11. Global Postpartum Depression Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Postpartum Depression Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Postpartum Depression Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Postpartum Depression Therapeutics Market Share by Players in 2019
Figure 16. Global Top Postpartum Depression Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postpartum Depression Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Postpartum Depression Therapeutics Revenue in 2019
Figure 18. North America Postpartum Depression Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Postpartum Depression Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Postpartum Depression Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Postpartum Depression Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Postpartum Depression Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Postpartum Depression Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Postpartum Depression Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

産後うつ病治療の世界市場（～2026年）

Global Postpartum Depression Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04334 2020年11月20日 93Pages
当調査資料は産後うつ病治療のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、その他の抗うつ薬）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

うつ病治療療法の世界市場（～2026年）

Global Depression Treatment Therapy Market Size, Status and Forecast 2020-2026
MRC2-11QY11618 2020年11月25日 125Pages
当調査資料はうつ病治療療法のグローバル市場について調査・分析したレポートです。種類別（医薬品、治療装置）市場規模、用途別（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、双極性障害）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

不安障害・うつ病治療の世界市場（～2026年）

Global Anxiety Disorders And Depression Treatment Market Insights and Forecast to 2026
MRC2-11QY02616 2020年11月20日 111Pages
当調査資料は不安障害・うつ病治療のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、治療・装置）市場規模、用途別（病院用、診療所用、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

CNS治療薬の世界市場（～2026年）

Global CNS Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11420 2020年11月25日 130Pages
当調査資料はCNS治療薬のグローバル市場について調査・分析したレポートです。種類別（神経変性疾患、気分障害、統合失調症、自閉症、うつ病）市場規模、用途別（病院、クリニック、家庭、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

血友病A・B治療材料の世界市場（～2026年）

Global Hemophillia A and B Therapeutics Materials Market Size, Status and Forecast 2020-2026
MRC2-11QY12159 2020年11月25日 92Pages
当調査資料は血友病A・B治療材料のグローバル市場について調査・分析したレポートです。種類別（デスモプレシン、オクトコガルファ、ノナコガルファ、その他）市場規模、用途別（歯科医院、病院、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...

犬インフルエンザ治療薬の世界市場（～2026年）

Global Canine Flu Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11240 2020年11月25日 96Pages
当調査資料は犬インフルエンザ治療薬のグローバル市場について調査・分析したレポートです。種類別（ワクチン、その他）市場規模、用途別（獣医クリニック、獣医病院、動物医療施設）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

網膜静脈閉塞症治療薬の世界市場（～2026年）

Global Retinal Vein Occlusion Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04502 2020年11月20日 92Pages
当調査資料は網膜静脈閉塞症治療薬のグローバル市場について調査・分析したレポートです。種類別（網膜静脈分枝閉塞症、網膜中心静脈閉塞症）市場規模、用途別（病院、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

全身性乾癬治療薬の世界市場（～2026年）

Global Systemic Psoriasis Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04786 2020年11月20日 96Pages
当調査資料は全身性乾癬治療薬のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（軽度乾癬、中度乾癬、重度乾癬）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、...

皮膚糸状菌性爪真菌症治療薬（DOT）の世界市場（～2026年）

Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size, Status and Forecast 2020-2026
MRC2-11QY11621 2020年11月25日 93Pages
当調査資料は皮膚糸状菌性爪真菌症治療薬（DOT）のグローバル市場について調査・分析したレポートです。種類別（局所、経口療法）市場規模、用途別（病院、皮膚科・足病医院、独立薬局、通信販売薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

痛風治療薬の世界市場（～2026年）

Global Gout Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12069 2020年11月25日 91Pages
当調査資料は痛風治療薬のグローバル市場について調査・分析したレポートです。種類別（NSAID、コルチコステロイド、コルヒチン、尿酸低下薬）市場規模、用途別（急性痛風、慢性痛風）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

産後うつ病治療の世界市場（～2026年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Postpartum Depression Treatment Scope and Market Si…
うつ病治療療法の世界市場（～2026年） Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the …
うつ病性障害の世界市場（～2026年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…
抗うつ剤の世界市場（～2026年） Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperact…
ナルコレプシー治療薬の世界市場（～2026年） Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time. Market Analysis and Insights: Global Narcolepsy Therapeutics Mark…